Primary Hyperaldosteronism.
Cobb A, Aeddula NR.
2023 Dec 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Familial hyperaldosteronism type III.
Monticone S, Tetti M, Burrello J, Buffolo F, De Giovanni R, Veglio F, Williams TA, Mulatero P.
J Hum Hypertens. 2017 Dec;31(12):776-781. doi: 10.1038/jhh.2017.34. Epub 2017 Apr 27.
Familial forms and molecular profile of primary hyperaldosteronism.
Araujo-Castro M, Martín Rojas-Marcos P, Parra Ramírez P.
Hipertens Riesgo Vasc. 2022 Oct-Dec;39(4):167-173. doi: 10.1016/j.hipert.2022.05.007. Epub 2022 Jun 28.
Familial hyperaldosteronism type III a novel case and review of literature.
Pons Fernández N, Moreno F, Morata J, Moriano A, León S, De Mingo C, Zuñiga Á, Calvo F.
Rev Endocr Metab Disord. 2019 Mar;20(1):27-36. doi: 10.1007/s11154-018-9481-0.
Familial hyperaldosteronism.
Stowasser M, Gordon RD.
J Steroid Biochem Mol Biol. 2001 Sep;78(3):215-29. doi: 10.1016/s0960-0760(01)00097-8.
Familial hyperaldosteronism.
Torpy DJ, Stratakis CA, Chrousos GP.
Braz J Med Biol Res. 2000 Oct;33(10):1149-55. doi: 10.1590/s0100-879x2000001000004.
Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels.
Stowasser M, Wolley M, Wu A, Gordon RD, Schewe J, Stölting G, Scholl UI.
Curr Hypertens Rep. 2019 Apr 4;21(4):31. doi: 10.1007/s11906-019-0934-y.
A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III.
Mulatero P.
J Clin Endocrinol Metab. 2008 Aug;93(8):2972-4. doi: 10.1210/jc.2008-1241.
Bartter's syndrome: clinical findings, genetic causes and therapeutic approach.
Mrad FCC, Soares SBM, de Menezes Silva LAW, Dos Anjos Menezes PV, Simões-E-Silva AC.
World J Pediatr. 2021 Feb;17(1):31-39. doi: 10.1007/s12519-020-00370-4. Epub 2020 Jun 1.
Pathophysiology of bilateral hyperaldosteronism.
Nanba K, Rainey WE.
Curr Opin Endocrinol Diabetes Obes. 2022 Jun 1;29(3):233-242. doi: 10.1097/MED.0000000000000729.
